• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Regulatory

Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.

Multiple sclerosis.
Posted inAutoimmune Diseases, Neuroscience, New Drugs, Regulatory

Mayzent: New Drug for Treatment of Secondary Progressive Multiple Sclerosis

April 1, 2021September 8, 2022

Siponimod released by Novartis is an improved version of Gilenya.

Enhertu: Most Powerful Drug to Treat Advanced HER2-Positive Breast Cancer
Posted inNew Drugs, Oncology, Regulatory

Enhertu: Most Powerful Drug to Treat Advanced HER2-Positive Breast Cancer

March 31, 2021September 8, 2022

Trastuzumab deruxtecan, developed by AstraZeneca and Daiichi Sankyo, will save lives when Herceptin, Perjeta, and Kadcyla haven’t worked.

heart
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory

Arcalyst: World’s First Drug to Treat Recurrent Pericarditis

March 30, 2021September 8, 2022

Rilonacept by Kiniksa Pharmaceuticals will reduce recurrent pericarditis to almost nothing.

blood
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory

Zynteglo: Gene Therapy for Beta-thalassemia

December 4, 2020December 4, 2022

One dose of betibeglogene autotemcel will permanently eliminate the dependence on regular blood transfusions.

Posts navigation

Newer posts 1 … 10 11 12
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News